Horowitz NS - Search Results

1

Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.

Lin LH, Maestá I, St Laurent JD, Hasselblatt KT, Horowitz NS, Goldstein DP, Quade BJ, Sun SY, Braga A, Fisher RA, Berkowitz RS, Elias KM. Lin LH, et al. Among authors: horowitz ns. Am J Obstet Gynecol. 2021 Apr;224(4):372.e1-372.e30. doi: 10.1016/j.ajog.2020.09.048. Epub 2020 Oct 5. Am J Obstet Gynecol. 2021. PMID: 33031755

2

Vascularization and expression of angiogenic factors in partial and complete molar pregnancies.

Nagymanyoki Z, Growdon WB, Sarno J, Callahan MJ, Parast MM, Fulop V, Mok SC, Horowitz N, Berkowitz RS. Nagymanyoki Z, et al. J Reprod Med. 2008 Aug;53(8):589-94. J Reprod Med. 2008. PMID: 18773623

3

Management of gestational trophoblastic neoplasia.

Horowitz NS, Goldstein DP, Berkowitz RS. Horowitz NS, et al. Semin Oncol. 2009 Apr;36(2):181-9. doi: 10.1053/j.seminoncol.2008.12.009. Semin Oncol. 2009. PMID: 19332252 Review.

4

The epidemiology of ovarian granulosa cell tumors: a case-control study.

Boyce EA, Costaggini I, Vitonis A, Feltmate C, Muto M, Berkowitz R, Cramer D, Horowitz NS. Boyce EA, et al. Among authors: horowitz ns. Gynecol Oncol. 2009 Nov;115(2):221-5. doi: 10.1016/j.ygyno.2009.06.040. Epub 2009 Aug 7. Gynecol Oncol. 2009. PMID: 19664811

5

Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy.

Rodriguez N, Rauh-Hain JA, Shoni M, Berkowitz RS, Muto MG, Feltmate C, Schorge JO, Del Carmen MG, Matulonis UA, Horowitz NS. Rodriguez N, et al. Among authors: horowitz ns. Gynecol Oncol. 2012 May;125(2):362-6. doi: 10.1016/j.ygyno.2012.02.006. Epub 2012 Feb 12. Gynecol Oncol. 2012. PMID: 22333992

6

Prognostic determinants in patients with uterine and ovarian clear carcinoma.

Rauh-Hain JA, Winograd D, Growdon WB, Schorge JO, Goodman AK, Boruta DM, Berkowitz RS, Horowitz NS, Del Carmen MG. Rauh-Hain JA, et al. Among authors: horowitz ns. Gynecol Oncol. 2012 May;125(2):376-80. doi: 10.1016/j.ygyno.2012.02.016. Epub 2012 Feb 21. Gynecol Oncol. 2012. PMID: 22366593

7

A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia.

Shah NT, Barroilhet L, Berkowitz RS, Goldstein DP, Horowitz N. Shah NT, et al. J Reprod Med. 2012 May-Jun;57(5-6):211-8. J Reprod Med. 2012. PMID: 22696815

8

Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma.

Rauh-Hain JA, Nitschmann CC, Worley MJ Jr, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, del Carmen MG, Horowitz NS. Rauh-Hain JA, et al. Among authors: horowitz ns. Gynecol Oncol. 2013 Apr;129(1):63-8. doi: 10.1016/j.ygyno.2013.01.009. Epub 2013 Jan 18. Gynecol Oncol. 2013. PMID: 23337490

9

Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery?

Worley MJ Jr, Guseh SH, Rauh-Hain JA, Williams KA, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS. Worley MJ Jr, et al. Among authors: horowitz ns. Gynecol Oncol. 2013 Apr;129(1):69-73. doi: 10.1016/j.ygyno.2013.01.012. Epub 2013 Jan 31. Gynecol Oncol. 2013. PMID: 23375727

10

Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia.

Maestá I, Growdon WB, Goldstein DP, Bernstein MR, Horowitz NS, Rudge MV, Berkowitz RS. Maestá I, et al. Among authors: horowitz ns. Gynecol Oncol. 2013 Aug;130(2):312-6. doi: 10.1016/j.ygyno.2013.05.017. Epub 2013 May 23. Gynecol Oncol. 2013. PMID: 23707672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters